These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 16567956)
21. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy. Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280 [TBL] [Abstract][Full Text] [Related]
22. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Rivella S; Sadelain M Semin Hematol; 1998 Apr; 35(2):112-25. PubMed ID: 9565154 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. May C; Rivella S; Callegari J; Heller G; Gaensler KM; Luzzatto L; Sadelain M Nature; 2000 Jul; 406(6791):82-6. PubMed ID: 10894546 [TBL] [Abstract][Full Text] [Related]
24. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease. Lebensburger J; Persons DA Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610 [TBL] [Abstract][Full Text] [Related]
25. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach. Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993 [TBL] [Abstract][Full Text] [Related]
26. Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia. Sadelain M; Rivière I; Wang X; Boulad F; Prockop S; Giardina P; Maggio A; Galanello R; Locatelli F; Yannaki E Ann N Y Acad Sci; 2010 Aug; 1202():52-8. PubMed ID: 20712772 [TBL] [Abstract][Full Text] [Related]
27. Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter. Sabatino DE; Seidel NE; Aviles-Mendoza GJ; Cline AP; Anderson SM; Gallagher PG; Bodine DM Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13294-9. PubMed ID: 11069298 [TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia. Morianos I; Siapati EK; Pongas G; Vassilopoulos G Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726 [TBL] [Abstract][Full Text] [Related]
30. In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction. Lung HY; Meeus IS; Weinberg RS; Atweh GF Blood Cells Mol Dis; 2000 Dec; 26(6):613-9. PubMed ID: 11358353 [TBL] [Abstract][Full Text] [Related]
31. Human globin gene expression after gene transfer. Bank A; Donovan-Peluso M; Lerner N; Rund D Blood Cells; 1987; 13(1-2):269-75. PubMed ID: 3478110 [TBL] [Abstract][Full Text] [Related]
32. Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach. Basak AN; Tuzmen S Methods Mol Biol; 2011; 700():291-307. PubMed ID: 21204041 [TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells. Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765 [TBL] [Abstract][Full Text] [Related]
34. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia. Dong AC; Rivella S Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680 [TBL] [Abstract][Full Text] [Related]
35. Future prospects for treatment of hemoglobinopathies. Stamatoyannopoulos JA West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285 [TBL] [Abstract][Full Text] [Related]
36. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients. Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321 [TBL] [Abstract][Full Text] [Related]
38. The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients. Persons DA Ann N Y Acad Sci; 2010 Aug; 1202():69-74. PubMed ID: 20712775 [TBL] [Abstract][Full Text] [Related]
40. An in vitro system for efficiently evaluating gene therapy approaches to hemoglobinopathies. Howrey RP; El-Alfondi M; Phillips KL; Wilson L; Rooney B; Lan N; Sullenger B; Smith C Gene Ther; 2000 Feb; 7(3):215-23. PubMed ID: 10694798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]